Performance of wrist-worn home sleep apnea testing (watch-PAT) among individuals with chronic insomnia: a comparative study with polysomnography - Scorecard - MDSpire
Advertisement
Performance of wrist-worn home sleep apnea testing (watch-PAT) among individuals with chronic insomnia: a comparative study with polysomnography
Clinical Scorecard: Evaluation of Wrist-Worn Home Sleep Apnea Monitoring (Watch-PAT) in Patients with Chronic Insomnia: A Comparative Analysis with Polysomnography
At a Glance
Category
Detail
Condition
Key Mechanisms
Wrist-worn device measuring respiratory events using peripheral arterial tone (PAT) and pulse signals.
Target Population
Care Setting
Key Highlights
Sensitivity of Watch-PAT for identifying moderate-to-severe OSA was 77.3%.
Specificity of Watch-PAT was 100.0%.
Diagnostic agreement reached in 82% of subjects.
Watch-PAT overestimated total sleep time and REM sleep duration.
Guideline-Based Recommendations
Diagnosis
Use Watch-PAT for diagnosing moderate-to-severe OSA in patients with chronic insomnia.
Management
Consider polysomnography as the optimal diagnostic study for suspected OSA.
Monitoring & Follow-up
Interpret sleep duration and staging parameters from Watch-PAT with caution.
Risks
Comorbid insomnia and sleep apnea may lead to poorer daytime function and increased medical risks.
Patient & Prescribing Data
Adults aged 18-70 with chronic insomnia and suspected OSA.
Prior treatment for sleep apnea and certain medical histories were exclusion criteria.
Clinical Best Practices
Utilize home sleep apnea testing for convenience and cost-efficiency.
Ensure accurate assessment of sleep parameters when using wrist-worn devices.
Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody
